EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
26 10-2022

Alzheimer Europe Conference: Symposium on rethinking the early detection and diagnosis of Alzheimer’s disease

2022-10-27T09:41:23+00:0026-10-2022|News|

Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health needs. It represents between 60% and 70% of the dementia cases. It is still diagnosed too late when the symptoms become evident as the disease progresses.  AD is now portrayed as continuum consisting of 3 stages: [...]

24 05-2022

RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!

2022-05-24T07:55:53+00:0024-05-2022|News|

Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with [...]

Go to Top